Baylor Health Care System
 

Erythroblastosis fetalis

Definition

Erythroblastosis fetalis is a potentially life-threatening blood disorder in a fetus or newborn infant. This article provides a general overview. For more detailed information see the specific disorder:

Alternative Names

Hemolytic disease of the newborn

Causes

Erythroblastosis fetalis develops in an unborn infant when the mom and the baby have different blood types. The mother produces substances called antibodies that attack the developing baby's red blood cells.

The most common form of erythroblastosis fetalis is ABO incompatibility, which can vary in its severity.

The less common form is called Rh incompatibility, which more often causes a very severe anemia in the baby.

Review Date: 10/8/2007
Reviewed By: Deirdre O’Reilly, MD, MPH, Neonatologist, Division of Newborn Medicine, Children’s Hospital Boston and Instructor in Pediatrics, Harvard Medical School, Boston, Massachusetts. Review Provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission. URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2005 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.